RU2002121832A -
A method for the prevention of acute urinary retention after surgery in patients suffering from benign prostatic hyperplasia
- Google Patents
A method for the prevention of acute urinary retention after surgery in patients suffering from benign prostatic hyperplasia
Info
Publication number
RU2002121832A
RU2002121832ARU2002121832/14ARU2002121832ARU2002121832ARU 2002121832 ARU2002121832 ARU 2002121832ARU 2002121832/14 ARU2002121832/14 ARU 2002121832/14ARU 2002121832 ARU2002121832 ARU 2002121832ARU 2002121832 ARU2002121832 ARU 2002121832A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сибирский государственный медицинский университетfiledCriticalСибирский государственный медицинский университет
Priority to RU2002121832/14ApriorityCriticalpatent/RU2002121832A/en
Publication of RU2002121832ApublicationCriticalpatent/RU2002121832A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Claims (1)
Способ профилактики острой задержки мочеиспускания после оперативных вмешательств у пациентов, страдающих доброкачественной гиперплазией предстательной железы, включающий назначение медикаментозной терапии, отличающийся тем, что дополнительно в предоперационном периоде в течение 2-3 сут проводят обучение пациента мочеиспусканию в клиностатическом положении, назначают прием доксазозина мезиата в дозе 2 мг 2 раза в сутки за 12 ч до операции и в течение суток после операции, а также в послеоперационном периоде дополнительно назначают кеторолака трометамин в дозе 30 мг 2-4 раза в сутки в течение 3-4 сут.A method for the prevention of acute urinary retention after surgery in patients suffering from benign prostatic hyperplasia, including the appointment of drug therapy, characterized in that, in the preoperative period, the patient is trained to urinate in the clinostatic position for 2-3 days, a dose of doxazosin mesiate is prescribed in a dose 2 mg 2 times a day 12 hours before surgery and during the day after surgery, as well as in the postoperative period, ket is additionally prescribed orolaka tromethamine at a dose of 30 mg 2-4 times a day for 3-4 days.
RU2002121832/14A2002-08-072002-08-07
A method for the prevention of acute urinary retention after surgery in patients suffering from benign prostatic hyperplasia
RU2002121832A
(en)
The use of the non-opiate flupirtine analgesic for the treatment of hyperactivity of the urinary bladder and related diseases, including urgent urinary incontinence, has been reported to be very difficult.
Method of acute cholecystitis treatment 9240, ,0221 method of preventing explosion in discharged tank and in discharging granulated polymer 9240, ,0222 device for feeding fire-extinguishing composition in fire-extinguishing system